[1]郭晓燕,腾飞,张惠勇.川芎平喘合剂治疗慢性阻塞性肺疾病的随机对照研究[J].西部中医药,2018,31(01):1-4.
　GUO Xiaoyan,TENG Fei,ZHANG Huiyong.A Randomized, Controlled Study of ChuanXiong PingChuan Mixture in Treating Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(01):1-4.
点击复制

川芎平喘合剂治疗慢性阻塞性肺疾病的随机对照研究()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
31
期数:
2018年01期
页码:
1-4
栏目:
出版日期:
2018-01-07

文章信息/Info

Title:
A Randomized, Controlled Study of ChuanXiong PingChuan Mixture in Treating Chronic Obstructive Pulmonary Disease
文章编号:
1004-6852(2018)01-0001-04
作者:
郭晓燕，腾飞，张惠勇
上海中医药大学附属龙华医院肺病科，上海 200032
Author(s):
GUO Xiaoyan, TENG Fei, ZHANG Huiyong
Department of Pulmonary Disease, Longhua Hospital Shanghai University of TCM, Shanghai 200032, China
关键词:
慢性阻塞性肺疾病; CAT评分; 川芎平喘合剂
Keywords:
chronic obstructive pulmonary disease;  CAT scales;  ChuanXiong PingChuan mixture
分类号:
R243
文献标志码:
A
摘要:
目的：评价川芎平喘合剂治疗慢性阻塞性肺疾病(COPD)的临床疗效。方法：将COPD患者144例按随机数字表法分为对照组和治疗组各72例。对照组给予西医常规联合安慰剂治疗，治疗组在西医常规治疗基础上给予川芎平喘合剂，疗程21天。观察治疗前后2组患者COPD评估测试(CAT)评分及中医证候积分等指标。结果：治疗后治疗组喘息、胸闷、气短积分及中医证候积分总分均低于对照组（P＜0.05)；治疗组患者咳嗽、胸闷、气喘等CAT评分较对照组降低（P＜0.05)，做事、外出信心、睡眠、精力等CAT评分低于对照组，但差异无统计学意义（P＞0.05)；2组患者动脉血氧分压(Pa02)、二氧化碳分压(PaC02)均较治疗前改善（P＜0.05)；治疗组Pa02、PaC02改善程度优于对照组（P＜0.05)。治疗后2组第1秒用力呼气容积占预计值百分比(FEV1%pred)水平高于治疗前，差异具有统计学意义（P＜0.05)，治疗组FEV1%pred水平高于对照组，但差异无统计学意义（P＞0.05)。结论：川芎平喘合剂结合西医常规治疗COPD可进一步改善患者咳嗽、咯痰、胸闷、呼吸困难等临床症状和生活质量。
Abstract:
Objective: To assess clinical effects of ChuanXiong PingChuan mixture in treating chronic obstructive pulmonary disease(COPD). Methods: All 144 COPD patients were divided into the control group and the treatment group according to random number table method, 72 cases each group. The control group accepted routine treatment of western medicine and placebo, and the treatment group took ChuanXiong PingChuan mixture on the foundation of routine treatment of western medicine, for 21 days. CAT scales and TCM syndrome scales of both groups were observed before and after treating. Results: After treating, the treatment group was lower than the control group in the scales of panting, choking sensation in chest, breathing hard and TCM syndrome scales (P＜0.05); the decrease of CAT scales including cough, choking sensation in chest and panting in the treatment group were more obvious compared with the control group (P＜0.05), lower than the control group in CAT scales such as working, out-of-office, confidence, sleep, energy and others, while the difference had no statistical meaning (P＞0.05); PaO2 and PaCO2 of both groups improved compared with before treating(P＜0.05); the improvements of PaO2 and PaCO2 in the treatment group were superior to these of the control group(P＜0.05). After treating, the levels of FEV1%pred of both groups were higher than these before treating, and the difference had statistical meaning(P＜0.05), the treatment group was higher than the control group in the levels of FEV1%pred, but the difference had no statistical meaning(P＞0.05). Conclusion: ChuanXiong PingChuan mixture combined with routine treatment of western medicine in treating COPD could improve clinical symptoms including cough, sputum, choking sensation in chest, dyspnea, and others, as well as quality of life further.

相似文献/References:

[1]王萍.慢性阻塞性肺病患者实施临床护理路径的疗效分析[J].西部中医药,2014,27(11):140.
[2]王 燕,孙凤英,倪 军.慢性阻塞性肺疾病患者非药物治疗依从性与生活质量相关性的研究[J].西部中医药,2015,28(03):89.
[3]郭晓燕,尹广超,陆城华,等.川芎平喘合剂对COPD患者血管内皮功能的调节作用[J].西部中医药,2015,28(05):1.
[4]王振伟,杨佩兰,沈丽,等.百部养肺煎膏治疗COPD稳定期患者的临床研究[J].西部中医药,2015,28(05):56.
[5]赵宇冰,林丽明.老年慢性阻塞性肺疾病患者缓解期的社区康复治疗[J].西部中医药,2012,25(08):59.
　ZHAO Yu-bing,LIN Li-ming.Community Rehabilitation Therapy for Senile Patients with COPD at Remission Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(01):59.
[6]张旭辉,杨虹.咳喘宁胶囊治疗稳定期慢性阻塞性肺疾病的疗效评价[J].西部中医药,2016,29(03):1.
　ZHANG Xuhui,YANG Hong.Evaluation of Clinical Effects of KeChuanNing Capsules in Treating Chronic Obstructive Pulmonary Disease at Stable Stage[J].Western Journal of Traditional Chinese Medicine,2016,29(01):1.
[7]晏燕,孙建勤,姜冰玉,等.中西医结合治疗老年慢性阻塞性肺疾病急性加重期的临床疗效[J].西部中医药,2016,29(07):96.
　YAN Yan,SUN Jianqin,JIANG Bingyu,et al.Clinical Effects of Integrative Medicine in Treating Chronic Obstructive Pulmonary Disease of Senile Patients at Acute Exacerbation[J].Western Journal of Traditional Chinese Medicine,2016,29(01):96.
[8]施巍,苟小军,王道才,等.刺络放血法治疗慢性阻塞性肺疾病急性加重期48例[J].西部中医药,2017,30(02):96.
　SHI Wei,GOU Xiaojun,WANG Daocai,et al.Blood-letting Therapy in Treating 48 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation Stage[J].Western Journal of Traditional Chinese Medicine,2017,30(01):96.
[9]史素丽,尚秀娟△,曹凤英.老年慢性阻塞性肺疾病患者主观幸福度及影响因素分析[J].西部中医药,2016,29(01):93.
　SHI Suli,SHANG Xiujuan,CAO Fengying.Analysis of Influencing Factors and Subjective Happiness Index of Senile Patients with Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2016,29(01):93.
[10]韩敏娟,曹鹏鹏,胡建明,等.慢性阻塞性肺疾病不同表型与中医证型的相关性研究[J].西部中医药,2016,29(03):63.
　HAN Minjuan,CAO Pengpeng,HU Jianming,et al.Correlation Study between Clinical Phenotypes of Chronic Obstructive Pulmonary Disease and TCM Patterns[J].Western Journal of Traditional Chinese Medicine,2016,29(01):63.
[11]主父瑶.河车虫草胶囊联合八段锦治疗慢性阻塞性肺疾病稳定期疗效观察[J].西部中医药,2018,31(03):89.
　ZHU Fuyao.Observation on Clinical Effects of HeChe ChongCao Capsules Combined with Eight-section Brocade in Treating Chronic Obstructive Pulmonary Disease at Stationary Phase[J].Western Journal of Traditional Chinese Medicine,2018,31(01):89.

备注/Memo

备注/Memo:
收稿日期：2017-06-22 *基金项目：国家青年自然基金项目(编号81202922)；上海市科委医学与农业领域项目(编号13401901705)。 作者简介：郭晓燕(1980—)，男，博士学位，副主任医师。研究方向：呼吸系统疾病的中医药防治。
更新日期/Last Update: 2018-01-15